Interim CEO Brent Shafer said the medical products maker is ready to begin a new era after several years of “heavy lifting” ...

Baxter International (NYSE:BAX – Get Free Report) had its price objective dropped by analysts at JPMorgan Chase & Co. from ...

Key Takeaways Baxter International shares soared Thursday after the company's fourth-quarter results topped estimates.The ...

Shares of Baxter International (NYSE:BAX) traded higher in the premarket on Thursday after the medical product maker reported ...

The Deerfield, Illinois-based medtech company reported losses of $512 million. That equals $1 per share on sales of $2.75 ...

Baxter International’s largest manufacturing plant is back up to regular production levels nearly five months after it was ...

While being a session player can sometimes be a thankless job, Baxter recalls a particularly memorable session with Steely Dan producer Gary Katz ...

Barclays began coverage on shares of Baxter International (NYSE:BAX – Free Report) in a report released on Thursday, Marketbeat reports. The brokerage issued an overweight rating and a $39.00 price ...

Following the completion of a massive restructuring plan, the medical equipment giant projects 4% to 5% sales growth this ...

A Baxter International intravenous manufacturing plant in North Carolina is back up and running at full capacity after it ...

Shares of Baxter International on Thursday rose on pace for the largest percent increase since March 2020 after fourth-quarter sales and outlook for the first quarter and 2025 beat Wall Street ...

Barclays reinstated coverage of Baxter (BAX) with an Overweight rating and $39 price target The firm updated its sales projections to reflect ...